"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

The Company is seeking approval of tirzepatide for the treatment of HFpEF and obesity and has submitted data to the ... and the change in the Kansas City Cardiomyopathy Questionnaire Clinical Summary ...

This love-hate tension is all part of fast food’s complex place in our lives. A report published Thursday in the journal The ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

The treatment of obesity as a disease, especially with some of the newer medical treatments, is not standard of care and ...

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

On Saturday, Eli Lilly And Co (NYSE:LLY) released detailed results from the SUMMIT Phase 3 trial showing tirzepatide reduced ...

In The Lancet Diabetes & Endocrinology, Yair Zloof and colleagues1 show that obesity in otherwise healthy adolescents was ...

Obesity is associated with self-reported symptoms of depression, eating disorders, and/or binge eating among treatment-seeking adolescents.

Eli Lilly and Co. (LLY) has released detailed findings from the Phase 3 SUMMIT trial, demonstrating that tirzepatide significantly ...

Childhood maltreatment — especially physical abuse and neglect — was associated with increased risks for adulthood obesity and type 2 diabetes.